Burge, Matthew
99  results:
Search for persons X
?
 
?
 
?
5

Phase II Open-Label Study of Pembrolizumab in Treatment-Ref..:

Le, Dung, T ; Kim, Won ; Cutsem, Eric, Van...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41389-018-0079-x.  , 2021
 
?
6

Phase II Open-Label Study of Pembrolizumab in Treatment-Ref..:

Le, Dung, T ; Kim, Won ; Cutsem, Eric, Van...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41389-018-0079-x.  , 2021
 
?
8

Phase II Open-Label Study of Pembrolizumab in Treatment-Ref..:

Le, Dung, T ; Kim, Won ; Cutsem, Eric, Van...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41389-018-0079-x.  , 2021
 
?
9

The prognostic role of inflammatory markers in patients wit..:

Clarke, Stephen ; Burge, Matthew ; Feeney, Kynan...
Clarke , S , Burge , M , Feeney , K , Gibbs , P , Jones , K , Marx , G , Molloy , M P , Price , T , Reece , W H H , Segelov , E & Tebbutt , N C 2020 , ' The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab : a translational study [ASCENT] ' , PLoS ONE , vol. 15 , no. 3 , e0229900 , pp. 1-11 . https://doi.org/10.1371/journal.pone.0229900.  , 2020
 
?
 
?
11

Simulating Progression-Free and Overall Survival for First-..:

Degeling, Koen ; Wong, Hui Li ; Koffijberg, Hendrik...
Degeling , K , Wong , H L , Koffijberg , H , Jalali , A , Shapiro , J , Kosmider , S , Wong , R , Lee , B , Burge , M , Tie , J , Yip , D , Nott , L , Khattak , A , Lim , S , Caird , S , Gibbs , P & IJzerman , M 2020 , ' Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data ' , PharmacoEconomics , vol. 38 , no. 11 , pp. 1263-1275 . https://doi.org/10.1007/s40273-020-00951-1.  , 2020
 
1-15